Check the source.
Ask how to verify the medical lead’s license or professional registration independently. A name, role, and jurisdiction should be specific enough to check.
Rosarito, Baja California
Clinic Due Diligence
A practical, evidence-aware checklist for prospective patients and families assessing ibogaine programs in Rosarito. The purpose is not to endorse a provider, but to make the questions, documents, and warning signs clearer before decisions are made.
A measured starting point
Begin with records, not reassurance.
When comparing programs, ask for concrete materials early: who carries medical responsibility, what written protocols guide screening and monitoring, how emergencies are handled, and how concerns are recorded. A clear answer is not a promise of quality, but persistent vagueness is useful information.
The broader Rosarito guide can help place those questions in local context. For the organization’s boundaries and approach to information, see Costa Senda’s stated mission and principles.
“Due diligence is a process of confirming what can be confirmed—and naming what cannot.”
Local setting does not replace the need for independently verifiable safety information.
Step one
Request the documentation that makes care legible.
Ask a program to identify its medical director or the clinician with medical responsibility, describe that person’s qualifications, and explain how those credentials may be checked. Professional titles alone are not verification. Where a registry is available, use it directly rather than relying only on a website or testimonial.
Also ask for written screening criteria, informed-consent materials, medication policies, emergency-response procedures, and a description of telemetry or other monitoring capability. The FDA’s drug safety information is a useful reminder that adverse effects and interactions require careful clinical attention, not casual assumptions.
- Who is medically responsible during assessment, dosing, monitoring, and an emergency?
- Can the program provide written screening, consent, medication, and escalation policies?
- What monitoring is available, who interprets it, and when is it used?
- How are adverse events documented, reviewed, and communicated?
- What is the plan if a person needs transfer to a higher level of care?
Step two
Turn answers into things you can verify.
Useful due diligence goes beyond asking whether a program has a plan. Request a copy of the relevant policy, or ask for a clear explanation of why a copy cannot be shared. Confirm the local hospital or emergency-transfer relationship described, including how a transfer would actually be arranged. Avoid treating a general statement of affiliation as evidence of a current, usable pathway.
Ask operationally.
“Monitoring” can mean different things. Ask what is monitored, when, by whom, and what triggers a change in care or emergency response.
Ask what is recorded.
Programs should be able to explain how adverse events are documented and reviewed, without making blanket assurances that serious problems do not occur.
Cardiac rhythm issues are one reason specificity matters. The basic role of electrocardiography is to record the heart’s electrical activity; a prospective patient can still ask how any equipment is used and who is qualified to respond to findings.
Step three
Notice what a program will not make clear.
One unanswered question is not automatically disqualifying; privacy, individual circumstances, and local rules can limit what is shared. The pattern matters. Opaque answers on consent, monitoring, emergency response, or who is accountable deserve careful attention.
Be especially cautious about claims that minimize risk or frame screening as unnecessary. Informed consent is an established ethical principle in health care, and the World Health Organization’s patient-safety work emphasizes systems designed to reduce avoidable harm rather than simple assurances.
No identifiable medical oversight. A program cannot plainly say who holds medical responsibility or how qualifications can be checked.
Opaque or pressured consent. Written risks, alternatives, exclusions, and the chance to ask questions are minimized or rushed.
No practical post-care plan. There is no clear plan for follow-up, medication continuity, records, or what happens if recovery is complicated.
Unverifiable emergency claims. A program names emergency resources but cannot explain its procedures for activating them.
Explanatory FAQ
Questions worth taking slowly.
What documentation is reasonable to request before considering a program?
Reasonable requests include written screening criteria, informed-consent materials, emergency-response procedures, monitoring information, medication and escalation policies, and a post-care plan. A program should be able to explain what it can share and why any information cannot be shared. For a broader evidence-aware discussion of ibogaine-related questions, consult ibogaine and neurological research context, while remembering that research discussion is not a substitute for individualized medical advice.
How can a family member verify medical oversight?
Ask who holds medical responsibility, what their qualifications are, how those qualifications can be independently checked, and who is physically available during treatment. Confirming professional registration directly is more useful than relying on marketing language. If medication history is part of the conversation, the safety and screening considerations may help organize further questions for a qualified clinician.
What should count as a serious red flag?
Serious concerns include no identifiable medical oversight, vague or pressured consent, no clear emergency plan, refusal to discuss monitoring, blanket assurances of safety, and no practical plan for post-care or transfer of care. These are reasons to pause, seek independent professional input, and avoid allowing urgency to replace verification.
Can this checklist determine whether a program is safe or appropriate?
No. A checklist can clarify questions and expose gaps, but it cannot establish clinical suitability, predict outcomes, or replace an assessment by a qualified health professional familiar with a person’s medical history. It also does not endorse any provider or support self-administered ibogaine.
A practical standard
Keep a written record of what was asked and answered.
Save policies, dates, names of responsible roles, and the precise answers given about screening, monitoring, emergency transfer, and follow-up. This makes it easier for a prospective patient, family member, or independent clinician to distinguish a documented process from a broad claim.
This page is for general information only. It does not recommend a clinic, rank programs, provide medical or legal advice, or advise anyone to use ibogaine.